“…The pEGFP-eGFP-matrix attachment region (MAR) plasmid, which contains the CMV promoter and MAR element, was previously constructed in our laboratory [31][32][33][34][35][36]. The CAG (GenBank accession no: GU299216.1, position 3-1664), HEF-1a (accession no: AY188393.1, position 10964-12623), CMV mutant, CHEF-1a (accession no: KY447299.1, position 12-1346), CAG enhancer (accession no: AJ575208.1, position 100-386), mouse CMV (accession no: KT343252.1, position 1103-1625), and PGK (accession no: KJ175229.1, position 641-1195) [37] promoters were synthesized and used to replace the CMV promoter in the pEGFP-eGFP vector (Fig.…”